Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · IEX Real-Time Price · USD
6.93
+0.26 (3.90%)
At close: May 31, 2024, 4:00 PM
7.02
+0.09 (1.30%)
After-hours: May 31, 2024, 7:33 PM EDT
Orchestra BioMed Holdings Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for OBIO stock have an average target of 17, with a low estimate of 14 and a high estimate of 20. The average target predicts an increase of 145.31% from the current stock price of 6.93.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 28, 2024.
Analyst Ratings
The average analyst rating for OBIO stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +188.60% | Mar 28, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +102.02% | Jan 19, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +188.60% | Aug 11, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +188.60% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +188.60% | May 15, 2023 |
Financial Forecast
Revenue This Year
3.25M
from 2.76M
Increased by 17.90%
Revenue Next Year
3.60M
from 3.25M
Increased by 10.51%
EPS This Year
-1.57
from -1.48
EPS Next Year
-1.57
from -1.57
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.4M | 4.5M | 871,500 | 12.6M | 36.8M |
| Avg | 3.3M | 3.6M | 846,600 | 8.2M | 31.8M |
| Low | 3.0M | 2.7M | 813,400 | 4.0M | 26.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 24.8% | 38.8% | -75.8% | 1,388.3% | 347.1% |
| Avg | 17.9% | 10.5% | -76.5% | 870.9% | 287.0% |
| Low | 10.1% | -17.2% | -77.4% | 376.7% | 226.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.55 | -1.61 | -1.45 |
| Avg | -1.57 | -1.57 | -1.41 |
| Low | -1.56 | -1.52 | -1.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.